上海市32家样本医院2009-2012年抗肿瘤药应用分析

发布时间：2019-03-11 12:46

【摘要】：目的:为临床合理使用抗肿瘤药提供参考。方法:调取上海市32家样本医院2009-2012年用药数据,运用Excel统计分析抗肿瘤药的销售金额、年同比增长率、市场份额以及科室分布等,并对样本医院及抗肿瘤药进行分类汇总、排序。结果:4年间抗肿瘤药用量增长迅速,2012年销售金额增长率达12.80%;从治疗大类分析,抗肿瘤中成药、抗代谢药和抗肿瘤植物药一直稳居销售金额前三位,总计占所有类别抗肿瘤药的50%以上,在恶性肿瘤的治疗中发挥着举足轻重的作用;从具体品种分析,多西他赛和卡培他滨的市场份额最大,销售金额始终排序前2位,而培美曲塞和替吉奥胶囊则是增速较快的2个品种。结论:近年来,抗肿瘤药物的应用呈现快速增长趋势,高选择性、高效低毒性的抗肿瘤药需求增大,抗肿瘤中成药应用广泛。
[Abstract]:Objective: to provide reference for rational use of antineoplastic drugs in clinic. Methods: the data of drug use were collected from 32 sample hospitals in Shanghai from 2009 to 2012, and the sales amount, annual year-on-year growth rate, market share and department distribution of antineoplastic drugs were analyzed by Excel, and the sample hospitals and antineoplastic drugs were classified and summarized. Sort. Results: the consumption of anti-tumor drugs increased rapidly in the last 4 years, and the amount of sales increased by 12.80% in 2012. From the analysis of treatment categories, anti-tumor Chinese patent drugs, anti-metabolic drugs and anti-tumor plant drugs have been in the top three sales, accounting for more than 50% of all kinds of anti-tumor drugs, playing an important role in the treatment of malignant tumors; From the specific variety analysis, docetaxel and capecitabine have the largest market share, the sales amount has always ranked the top two, while Pemetrexil and Tigio capsules are the two fastest-growing varieties. Conclusion: in recent years, the use of antineoplastic drugs showed a rapid growth trend, high selectivity, high efficiency and low toxicity of antineoplastic drugs demand increased, anti-tumor Chinese patent drugs are widely used.
【作者单位】：上海市松江区中心医院;中国医药工业信息中心;
【分类号】：R95

【参考文献】